Refining the bioactivity of P42, a hit therapeutic peptide, and developing a combined therapeutic peptide approach for treating Huntington’s Disease.

Project Number
EUJPND-FranceANR-MASCHAT-646
Agency/Funding Organization
Agence Nationale de la Recherche (ANR)
Funding Year
2016
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
F
Principal Investigator Last Name
MASCHAT
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$59,577
Funding Organization